Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | ALB | P02768 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | AHCY | P23526 | 1/20 | 0.54 |
| ▸ | PNP | P00491 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | ADA | P00813 | 1/20 | 0.46 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25712959 | 1.00 | LMNA (0.59) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL21277438 | 0.90 | AHCY (0.49) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL12154625 | 0.89 | ALDH1A1 (0.58) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL7435133 | 0.89 | LMNA (0.58) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL8124562 | 0.88 | LMNA (0.65) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL2808298 | 0.88 | LMNA (0.58) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL887901 | 0.88 | LMNA (0.60) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL22862138 | 0.88 | LMNA (0.58) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL5548925 | 0.88 | LMNA (0.57) | LMNAALDH1A1ALBMAPK1CYP1A2 | |
| SCHEMBL12149469 | 0.88 | ALDH1A1 (0.57) | LMNAALDH1A1ALBMAPK1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12480106-B2 | Reactions with non-retroviral reverse transcriptase | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-25 | — | — | US | claimed |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | BICYCLE TX LTD (GB) | 2025-10-23 | — | — | US | claimed |
| CN-117081436-B | Permanent magnet synchronous motor current control method and system | 中国科学院长春光学精密机械与物理研究所 | 2025-02-11 | — | — | CN | claimed |
| WO-2025005781-A1 | ANTIMICROBIAL PEPTOID COMPRISING N-TERMINAL METAL COMPLEX | 광주과학기술원 | 2025-01-02 | — | — | WO | claimed |
| US-20240352073-A1 | BICYCLIC PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | JANSSEN BIOTECH INC (US) | 2024-10-24 | — | — | US | claimed |
| US-12083223-B2 | Nanolipoprotein particles and related compositions methods and systems for loading RNA | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2024-09-10 | — | — | US | claimed |
| US-20240209027-A1 | PEPTIDE AND PEPTIDE-CONTAINING COMPOSITION | PEPTIAID INC (JP) | 2024-06-27 | — | — | US | claimed |
| US-20240207186-A1 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2024-06-27 | — | — | US | claimed |
| CN-114648659-B | Light-weight concrete bridge disease identification method based on transfer learning | 北京工业大学 | 2024-06-07 | — | — | CN | claimed |
| CN-117858889-A | Peptides and compositions comprising peptides | 肽爱德股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-11021497-B2 | Compositions and methods for synthesis of phosphorylated molecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-06-01 | — | — | US | claimed |
| US-20200239500-A1 | Compositions and Methods for Synthesis of Phosphorylated Molecules | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-07-30 | — | — | US | claimed |
| US-7807653-B2 | Nucleotide mimics and their prodrugs | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2010-10-05 | — | — | US | claimed |
| US-20070265224-A1 | Nucleotide mimics and their prodrugs | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2007-11-15 | — | — | US | claimed |
| EP-1485395-A2 | NUCLEOTIDE MIMICS AND THEIR PRODRUGS | Biota, Inc. (US) | 2004-12-15 | — | — | EP | claimed |
| WO-2003072757-A9 | NUCLEOTIDE MIMICS AND THEIR PRODRUGS | BIOTA INC (US) | 2004-10-21 | — | — | WO | claimed |
| US-20040059104-A1 | Nucleotide mimics and their prodrugs | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2004-03-25 | — | — | US | claimed |
| WO-2003072757-A2 | NUCLEOTIDE MIMICS AND THEIR PRODRUGS | BIOTA, INC. (US) | 2003-09-04 | — | — | WO | claimed |
| EP-0374096-B1 | COMBINATION THERAPY INVOLVING 2',3'-DIDEOXYPURINE NUCLEOSIDE AND AN INHIBITOR OF PURINE NUCLEOSIDE PHOSPHORYLASE, AND ITS COMPOSITIONS | CIBA-GEIGY AG (CH) | 1992-12-02 | — | — | EP | claimed |
| EP-0374096-A1 | Combination therapy involving 2',3'-dideoxypurine nucleoside and an inhibitor of purine nucleoside phosphorylase, and its compositions | CIBA-GEIGY AG (CH) | 1990-06-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070265224-A1 | Nucleotide mimics and their prodrugs | NUDT14, ENTPD5, MTAP | LMNA 3677/4885ALDH1A1 2112/4885ALB 4137/4885 |
| US-20250325672-A1 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | ACE2, SARS1, TMPRSS2 | LMNA 2785/4885ALDH1A1 4812/4885ALB 816/4885 |
| US-20200239500-A1 | Compositions and Methods for Synthesis of Phosphorylated Molecules | PIK3CA, CHAMP1, TYMP | LMNA 1794/4885ALDH1A1 4371/4885ALB 2637/4885 |
| US-12083223-B2 | Nanolipoprotein particles and related compositions methods and systems for loading RNA | SARNP, SYNCRIP, AUP1 | LMNA 432/4885ALDH1A1 4836/4885ALB 1691/4885 |
| US-20240209027-A1 | PEPTIDE AND PEPTIDE-CONTAINING COMPOSITION | NGLY1, VIP, HM13 | LMNA 2115/4885ALDH1A1 4859/4885ALB 3856/4885 |
| US-11021497-B2 | Compositions and methods for synthesis of phosphorylated molecules | PIK3CA, CHAMP1, TYMP | LMNA 1794/4885ALDH1A1 4371/4885ALB 2637/4885 |
| US-20240352073-A1 | BICYCLIC PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | IL23R, IL1RN, IL17A | LMNA 4245/4885ALDH1A1 4643/4885ALB 2133/4885 |
| US-20240207186-A1 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA | SARNP, SYNCRIP, AUP1 | LMNA 432/4885ALDH1A1 4836/4885ALB 1691/4885 |
| US-20040059104-A1 | Nucleotide mimics and their prodrugs | NUDT14, ENTPD5, MTAP | LMNA 3677/4885ALDH1A1 2112/4885ALB 4137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.